Current treatment with EES is associated with a lower risk of very late stent thrombosis compared with early-generation drug-eluting stents.
No takes yet. Share an insight, caveat, or question.
Räber et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: